Deborah Birx is Chief Executive Officer of Armata Pharmaceuticals, Inc. (ARMP). The company reported total compensation of $1,249,889 for fiscal year 2025.
| Salary | $562,380 |
|---|---|
| Bonus | — |
| Stock awards | — |
| Option awards | $397,981 |
| Non-equity incentive plan | $281,190 |
| Pension and non-qualified deferred compensation | — |
| All other compensation | $8,338 |
| Total | $1,249,889 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Armata Pharmaceuticals, Inc. filed April 27, 2026, accession 0001104659-26-049437.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Deborah Birx this page | Chief Executive Officer | $1,249,889 |
| Pierre Kyme | Chief Business Officer | $791,575 |
| David House | Senior Vice President, Finance and Principal Financial Officer | $554,770 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Armata Pharmaceuticals, Inc. compensation brief.
Deborah Birx's compensation sits inside Armata Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.